Literature DB >> 26584294

MiR-203 Determines Poor Outcome and Suppresses Tumor Growth by Targeting TBK1 in Osteosarcoma.

Shiping Liu, Peng Feng.   

Abstract

BACKGROUND/AIMS: Increasing evidence has shown that miR-203 plays important role in human cancer progression. However, little is known about the function of miR-203 in osteosarcoma (OS).
METHODS: The expression of miR-203 in OS tissues and cell lines were examined by qRT-PCR. The biological role of miR-20 in OS cell proliferation was examined in vitro and in vivo. The targets of miR-203 were identified by a luciferase reporter gene assay.
RESULTS: miR-203 was down regulated in OS tissues and cell lines; decreased miR-203 was associated with a poor overall survival in OS patients. Restoration of miR-203 expression reduced cell growth in vitro and suppressed tumorigenicity in vivo. In contrast, inhibition of miR-203 stimulated OS cell growth both in vitro and in vivo. In addition, TANK binding kinase 1 (TBK1) was identified as a direct target of miR-203; overexpression of TBK1 partly reversed the suppressive effects of miR-203. Furthermore, TBK1 was found up-regulated and inversely correlated with miR-203 in OS tissues.
CONCLUSION: Taken together, these findings suggest that miR-203 acts as a tumor suppressor via regulation of TBK1 expression in OS progression, and miR-203 may be a promising therapeutic target for OS.
© 2015 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26584294     DOI: 10.1159/000438556

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  12 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Tumor-suppressive miR-99a inhibits cell proliferation via targeting of TNFAIP8 in osteosarcoma cells.

Authors:  Beiguang Xing; Cong Ren
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

3.  MicroRNA-203 suppresses gastric cancer growth by targeting PIBF1/Akt signaling.

Authors:  Shao-Jun Chu; Ge Wang; Peng-Fei Zhang; Rui Zhang; Yan-Xia Huang; Yun-Min Lu; Wei Da; Qun Sun; Jing Zhang; Jin-Shui Zhu
Journal:  J Exp Clin Cancer Res       Date:  2016-03-15

4.  Development and validation of nomogram based on miR-203 and clinicopathological characteristics predicting survival after neoadjuvant chemotherapy and surgery for patients with non-metastatic osteosarcoma.

Authors:  Dong Cheng; Xubin Qiu; Ming Zhuang; Chenlei Zhu; Hongjun Zou; Ailiang Zhang
Journal:  Oncotarget       Date:  2017-06-17

5.  Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.

Authors:  Jian-Sheng Wang; Ming-Yue Duan; Yong-Sheng Zhong; Xue-Dong Li; Shi-Xin Du; Peng Xie; Gui-Zhou Zheng; Jing-Ming Han
Journal:  Mol Med Rep       Date:  2019-01-30       Impact factor: 2.952

6.  miR‑494 inhibits cell proliferation and metastasis via targeting of CDK6 in osteosarcoma.

Authors:  Wei Yuan; Du Wang; Yang Liu; Dongdong Tian; Yang Wang; Ranxi Zhang; Liangjun Yin; Zhongliang Deng
Journal:  Mol Med Rep       Date:  2017-10-04       Impact factor: 2.952

7.  Omeprazole Inhibits Cell Proliferation and Induces G0/G1 Cell Cycle Arrest through Up-regulating miR-203a-3p Expression in Barrett's Esophagus Cells.

Authors:  Yichao Hou; Qiang Hu; Jiao Huang; Hua Xiong
Journal:  Front Pharmacol       Date:  2018-01-09       Impact factor: 5.810

8.  MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysis.

Authors:  Dong Cheng; Xubin Qiu; Ming Zhuang; Chenlei Zhu; Hongjun Zou; Zhiwei Liu
Journal:  Oncotarget       Date:  2017-07-05

9.  ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass.

Authors:  Ruben Jansen; Birte Moehlendick; Christoph Bartenhagen; Csaba Tóth; Nadja Lehwald; Nikolas H Stoecklein; Wolfram T Knoefel; Anja Lachenmayer
Journal:  Sci Rep       Date:  2018-07-13       Impact factor: 4.379

10.  MicroRNA‑203a‑3p is a candidate tumor suppressor that targets thrombospondin 2 in colorectal carcinoma.

Authors:  Zhenyuan Qian; Lijie Gong; Yiping Mou; Yong Han; Shusen Zheng
Journal:  Oncol Rep       Date:  2019-09-12       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.